Loading data...

Psilocybin and psilocin research index

Find psilocybin and psilocin papers, preprints, trials, and citations with clear source context.

Searches titles, authors, journals, identifiers, indexed metadata, and derived research topics. Use Filters to narrow by source, status, substance, study type, or date.

Database 4,975 indexed records Auto-updated on Aug 25, 2026 01:24 UTC

Executed search Author: Mitchell Low 108 matching records are displayed.

Clear search

Database

4,756 Psilocybin Records 674 Psilocin Records 1,463 Journals 66 Research Topics

Published 4,233 Peer-reviewed / formal records Preprints 438 Marked as not peer reviewed Clinical trials 301 ClinicalTrials.gov records R toolkit visNetwork Bibliometrics, live SQLite analysis, HTML graph, and PDF export

Top journals 1,463 indexed journals

Journal	Records
Journal of psychopharmacology (Oxford, England)	149
Journal of psychoactive drugs	97
Frontiers in psychiatry	90
Psychopharmacology	85
Neuroscience Applied	57
Journal of Psychedelic Studies	48
Psychedelic medicine (New Rochelle, N.Y.)	39
Scientific reports	37
Biological Psychiatry	32
Journal of affective disorders	32

Research topics 66 topic filters

Depression 1,741 Receptor Pharmacology 1,284 Safety 1,211 Review Article 1,076 Mechanism of Action 1,073 Clinical Trial 981 Anxiety 887 Addiction 826 Pharmacology 753 General 539 Aging 526 Animal Study 525 Observational Study 518 Brain Imaging 483 Treatment-Resistant Depression 417 Emotional Processing 410 Neuroplasticity 401 PTSD 401

Source coverage 8 active sources

Source	Count	Share	Status
PubMed	2,566	51.6%	Active
OpenAlex	1,156	23.2%	Active
Crossref	408	8.2%	Active
ClinicalTrials.gov	301	6.1%	Active
Europe PMC	194	3.9%	Active
PsyArXiv	186	3.7%	Active
bioRxiv	124	2.5%	Active

Publication timeline 3,872 dated records

3,872 records since 2020

Annual records Cumulative line

Reset all

Keyword search Author

Substances Psilocybin 4756 Psilocin 674

Date range quick select Last month Last year Last 5 years All time Custom range

Executed search Author: Mitchell Low 108 matching records are displayed.

Clear search

Filtered publication index

Search results

108 matching records for Author: Mitchell Low.

Select for export

Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.3389/fpsyt.2024.1406888 PubMed 38919636

Frontiers in psychiatry 2024-01-01 Szafoni S, Gręblowski P, Grabowska K, Więckiewicz G

PubMed Published psilocybin Depression Addiction OCD Clinical Trial More

Select for export

Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1176/appi.prcp.20240047 PubMed 39669539

Psychiatric research and clinical practice 2024-01-01 Bhagavan C, Kanaan R, Carter O, Nielsen G, Berlowitz D, Issak S

PubMed Published psilocybin Brain Imaging Aging Healthy Volunteers Clinical Trial More

Select for export

Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.12688/wellcomeopenres.22543.2

Wellcome open research 2024-01-01 Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K

PubMed Published psilocybin Brain Imaging Mechanism of Action Aging Other More

Select for export

Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1016/j.cub.2023.10.059 PubMed 38052161

Current biology: CB 2023-12-04 McTaggart AR, McLaughlin S, Slot JC, McKernan K, Appleyard C, Bartlett TL

PubMed Published psilocybin Pharmacology Drug Interactions Other More

Select for export

Psilocybin therapy to reduce depression following a terminal diagnosis.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1097/01.jaa.0000994952.07847.2d PubMed 37989175

JAAPA: official journal of the American Academy of Physician Assistants 2023-12-01 Boudreau E, Orlowski K

PubMed Published psilocybin Depression End-of-Life Distress Other More

Select for export

Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1089/psymed.2023.0018 PubMed 40046861

Psychedelic medicine (New Rochelle, N.Y.) 2023-12-01 Weintraub MJ, Jeffrey JK, Grob CS, Ichinose MC, Bergman RL, Cooper ZD

PubMed Published psilocybin Depression Mechanism of Action Clinical Trial Clinical Trial More

Select for export

Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphere

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.22541/au.170019739.91075425/v1

Authorea Preprints 2023-11-17 McTaggart A, Scarlett K, Slot J, Barlow C, Appleyard C, Gardiner D

Europe PMC PREPRINT (not peer reviewed) psilocybin Mechanism of Action Adverse Events Genomics Other More

Select for export

Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation study

No abstract availability was recorded for this entry.

Details DOI 10.1016/j.molliq.2023.123479

Journal of Molecular Liquids 2023-11-07 Lucas A. Paul, Cyril T. Namba-Nzanguim, Aidani Telesphory, Jehoshaphat Oppong Mensah, Denis Mteremko, Rene Costa

OpenAlex Published psilocybin General Other More

Select for export

Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.31234/osf.io/hm6jn

PsyArXiv 2023-10-14 Mathai DS, Roberts DE, Nayak SM, Sepeda ND, Lehrner A, Johnson M

PsyArXiv PREPRINT (not peer reviewed) psilocybin Chronic Pain Wellbeing Emotional Processing Observational Study More

Select for export

Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.31234/osf.io/hm6jn_v1

PsyArXiv 2023-10-14 Mathai DS, Roberts DE, Nayak SM, Sepeda ND, Lehrner A, Johnson M

PsyArXiv PREPRINT (not peer reviewed) psilocybin Chronic Pain Wellbeing Emotional Processing Observational Study More

Select for export

Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use

Abstract available at the source but not redistributed here. Read at source.

Details

PsyArXiv 2023-10-14 David S Mathai, Daniel E Roberts, Sandeep M Nayak, Nathan D Sepeda, Amy Lehrner, Matthew Johnson

PsyArXiv PREPRINT (not peer reviewed) psilocybin Chronic Pain Pharmacology Wellbeing Observational Study More

Select for export

Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-10-12 Yale University

ClinicalTrials.gov CLINICAL TRIAL psilocybin Headache / Migraine Safety Inflammation Clinical Trial More

Select for export

Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-10-12 Yale University

ClinicalTrials.gov CLINICAL TRIAL psilocybin Headache / Migraine Safety Clinical Trial More

Select for export

"Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli".

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1002/bit.28480 PubMed 37337917

Biotechnology and bioengineering 2023-08-01 Flower JE, Gibbons WJ, Adams AM, Wang X, Broude CN, Jones JA

PubMed Published psilocybin Mechanism of Action Other More

Select for export

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1192/bjo.2023.535 PubMed 37489299

BJPsych open 2023-07-25 Husain MI, Blumberger DM, Castle DJ, Ledwos N, Fellows E, Jones BDM

PubMed Published psilocybin Depression Receptor Pharmacology Consciousness Randomized Controlled Trial More

Select for export

In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1126/sciadv.adf8332 PubMed 37315149

Science advances 2023-06-16 Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C

PubMed Published psilocybin Brain Imaging Pharmacology Receptor Pharmacology Other More

Select for export

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.31234/osf.io/auycp

PsyArXiv 2023-06-09 Nayak SM, White S, Hilbert S, Lowe MX, Jackson H, Griffiths RR

PsyArXiv PREPRINT (not peer reviewed) psilocybin General Other More

Select for export

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.31234/osf.io/auycp_v1

PsyArXiv 2023-06-09 Nayak SM, White SH, Hilbert S, Lowe MX, Jackson H, Griffiths RR

PsyArXiv PREPRINT (not peer reviewed) psilocybin General Other More

Select for export

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study

Abstract available at the source but not redistributed here. Read at source.

Details

PsyArXiv 2023-06-09 Sandeep M Nayak, Sydney White, Samantha Hilbert, Matthew X Lowe, Heather Jackson, Roland R. Griffiths

PsyArXiv PREPRINT (not peer reviewed) psilocybin General Other More

Select for export

A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1101/2023.04.12.23288325

medRxiv 2023-04-19 Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R.

medRxiv PREPRINT (not peer reviewed) psilocybin Mystical Experience Clinical Trial Safety Clinical Trial More